Target intelligence / Profile preview

Fibroblast growth factor 6 (FGF6)

Target
FGF6
Molecular classification
Growth factor, Cytokine, Endogenous ligand
01

Overview

Fibroblast growth factor 6 (FGF6) is a member of the fibroblast growth factor family, acting as a cytokine and growth factor with key roles in cell proliferation, survival, and differentiation, especially in skeletal muscle regeneration and myogenic lineage commitment[1][2][5]. FGF6 is primarily expressed in muscle tissue, where it promotes expansion of muscle satellite cells and enhances regenerative potential, but it also has important systemic effects, such as modulating adipocyte thermogenesis and influencing bone remodeling by stimulating both osteoblast and osteoclast activity[2]. Dysregulation or aberrant expression of FGF6 is associated with tumorigenesis (notably in bladder cancer and hematologic malignancies), altered energy metabolism, and impaired tissue repair. FGF6 acts through binding and activating specific FGF receptors (FGFRs), resulting in complex downstream signaling that balances proliferation, differentiation, and tissue-specific functions[1][5][2].

Other names
FGF6FGF-6HST2HST-2HSTF2HSTF-2HBGF-6Heparin secretory-transforming protein 2Heparin-binding growth factor 6
02

Mechanism of action

Activation or modulation of fibroblast growth factor receptors (FGFRs), leading to downstream mitogenic, cell survival, and differentiation signaling pathways in responsive cells[5][2][1]

03

Biological functions

Cell proliferationCell differentiationMorphogenesisMuscle regenerationTissue repairRegulation of muscle stem cell (satellite cell) proliferationEnergy homeostasisBone remodeling
04

Disease associations

CancerMuscle dystrophy and myopathyMetabolic dysfunction (obesity/insulin sensitivity)Glioma susceptibilityHematologic cancer
05

Safety considerations

Oncogenic potential (displayed transforming activity in vitro, implicated in tumor growth and progression)Potential for fibrosis and aberrant tissue remodeling when dysregulatedRisks associated with systemic exposure, given its broad biological activity in multiple tissues[1][2][5]
06

Biomarkers

Upregulation or downregulation of FGF6 can serve as a marker for muscle regeneration capacity or myogenic satellite cell pool size, and is under investigation in metabolic dysfunction and various cancers[2][1]

Beyond the preview

Go deeper on Fibroblast growth factor 6 (FGF6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fibroblast growth factor 6 (FGF6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call